Lipotoxicity induced by saturated fatty acids (SFAs) plays a central role in the pathogenesis of nonalcoholic fatty liver disease (NAFLD); however, the exact mechanisms remain to be fully elucidated. Sirtuin 3 (SIRT3) is a nicotinamide adenine dinucleotide-dependent deacetylase located primarily inside mitochondria. In this study, we demonstrated that an SFA-rich highfat diet (HFD) was more detrimental to the liver than an isocaloric unsaturated HFD rich in fatty acids. Unexpectedly, SIRT3 expression and activity were significantly elevated in the livers of mice exposed to the SFA-rich HFD. Using cultured HepG2 and AML-12 hepatocytes, we demonstrated that unlike monounsaturated fatty acids, SFAs up-regulate SIRT3 expression and activity. SIRT3 overexpression renders both the liver and hepatocytes susceptible to palmitate-induced cell death, which can be alleviated by SIRT3 small interfering RNA (siRNA) transfection. In contrast, SIRT3 suppression protects hepatocytes from palmitate cytotoxicity. Further studies revealed that SIRT3 acts as a negative regulator of autophagy, thereby enhancing the susceptibility of hepatocytes to SFA-induced cytotoxicity. Mechanistic investigations revealed that SIRT3 overexpression causes manganese superoxide dismutase deacetylation and activation, which depleted intracellular superoxide contents, leading to adenosine monophosphate-activated protein kinase (AMPK) inhibition and mammalian target of rapamycin C1 activation, resulting in autophagy suppression. In contrast, SIRT3 siRNA gene silencing enhanced autophagy flux. A similar result was observed in the liver tissue of SIRT3 knockout mice. Conclusion: Our data indicate that SIRT3 is a negative regulator of autophagy whose activation by SFAs contributes to lipotoxicity in hepatocytes and suggest that restraining SIRT3 overactivation can be a potential therapeutic choice for the treatment of NAFLD as well as other metabolic disorders, with lipotoxicity being the principal pathomechanism. (HEPATOLOGY 2017;66:936-952).
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L ipotoxicity refers to cellular dysfunction and/or cell death derived from excess exposure to elevated levels of fatty acids and lipid accumulation in nonadipose tissues, including the liver, heart, skeletal muscle, and pancreas.
(1) Lipotoxicity accounts for many manifestations of the metabolic syndrome, including nonalcoholic fatty liver disease (NAFLD). (2) Hepatocyte cell death resulting from lipotoxicity, also called lipoapoptosis, is a hallmark of NAFLD. (3) Overall, lipotoxicity is most commonly induced by saturated Abbreviations: 2-ME, 2-methoxyestradiol; AAV, adeno-associated viral; AICAR, 5-aminoimidazole-4-carboxamide1-b-D-ribofuranoside; AMP, adenosine monophosphate; AMPK, adenosine monophosphate-activated protein kinase; ATP, adenosine triphosphate; EBSS, Earle's balanced salt solution; H 2 O 2 , hydrogen peroxide; HFD, high-fat diet; LC3, microtubule-associated protein 1 light chain 3; MnSOD, manganese superoxide dismutase; mTORC1, mammalian target of rapamycin C1; NAC, N-acetylcysteine; NAFLD, nonalcoholic fatty liver disease; O 2 fatty acids (SFAs), specifically palmitic acid (PA; 16:0), the most abundant SFA in the diet and in the circulation. (4) The cellular mechanisms underlying SFA-induced lipotoxicity in hepatocytes remain to be fully understood; however, it is well documented that endoplasmic reticulum stress and oxidative stress are the major intracellular pathways mechanistically involved in lipoapoptosis. (5, 6) Protecting hepatocytes from SFA-induced hepatotoxicity provides a conceivable strategy for preventing the development of NAFLD.
Autophagy is an evolutionarily conserved physiological process that represents a system of bulk protein degradation aimed at removal and breakdown of cellular components (organelles and proteins) during starvation, thereby redistributing nutrients for maintenance of cellular energetic balance. (7) It also plays a critical role in eliminating damaged proteins and organelles. (8) We reported previously that autophagy activation protected hepatocytes against SFA-induced lipotoxicity. (9) Similarly, autophagy activation confers protection against palmitate-induced cytotoxicity in pancreatic beta cells. (10) Sirtuins (SIRTs) are highly conserved nicotinamide adenine dinucleotide-dependent deacetylases that regulate a wide variety of biological functions. (11) (12) (13) (14) Of the seven mammalian sirtuins, SIRT3, SIRT4, and SIRT5 are predominantly localized inside mitochondria, with SIRT3 being considered as the primary modulator of mitochondrial protein acetylation. (15) SIRT3 is highly expressed in metabolically active tissues, such as the liver, and is a key regulator of mitochondrial functions, including metabolism, energy production, and modulation of the response to oxidative stress. (16) (17) (18) (19) (20) (21) The function of SIRT3 in cellular response is stimulus-and cell type-specific, (22) with both anti-apoptotic and proapoptotic activities being reported. (23) (24) (25) In the present study, we investigated the role of SIRT3 in SFA-induced hepatotoxicity. Unexpectedly, we found that the sensitivity of hepatocytes to SFAinduced lipotoxicity was positively associated with SIRT3 activity. Our detailed mechanistic investigations provide evidence for a novel role of SIRT3 in the regulation of autophagy induction via an adenosine monophosphate-activated protein kinase (AMPK)-dependent mechanism.
Materials and Methods

ANIMAL MODEL AND EXPERIMENTAL PROTOCOL
All animal studies were performed in accordance with the animal care committee at the University of Illinois at Chicago. All mice were fed ad libitum and were housed on a 12/12-hour light/dark cycle at 258C. Male SIRT3 2/2 mice and wild-type 129Sv mice (8 weeks of age) were purchased from The Jackson Laboratory (Bar Harbor, ME) and maintained on a standard chow diet. Male C57BL/6 mice (8-week old, Jackson Laboratory, Bar Harbor, ME) were fed a normal (n 5 8) or high-fat diet using either palm oil (n 5 8) or corn oil (n 5 8) as a fat source (Supporting Table S1 ; Bio-Serv, Flemington, NJ). For liver-specific SIRT3 overexpression, the animals were injected in the lateral tail vein with recombinant adeno-associated viral (AAV) serotype 8 gene transfer vectors bearing a liver-specific promoter combination (albumin promoter) with mouse SIRT3 sequence. The detailed protocols are shown in the Supporting Information. Mice were sacrificed 8 weeks later.
ARTICLE INFORMATION:
ESTABLISHMENT OF STABLE HUMAN SIRT3 OVEREXPRESSION CELL LINES
The eukaryotic expression vector plasmid pcDNA3.11/hSIRT3 containing the human SIRT3 gene sequence was kindly provided by Yu Wang (University of Hong Kong). (26) HepG2 cells were transfected with 0.8 lg/well of the expression vector pcDNA3.11/hSIRT3 or empty vector control pcDNA3.11 (Invitrogen, Grand Island, NY) in a 24-well plate using Lipofectamine 2000 reagent (Invitrogen, Grand Island, NY) following the manufacturer's guidelines. After 48 hours of transfection, cells were trypsinized into 24-well plates at a ratio of 1:100 for monoclonal cell selection using 800 lg/mL G418. The stable cell line was established and confirmed by both western blot analysis and real-time polymerase chain reaction. 
MANGANESE SUPEROXIDE DISMUTASE OVEREXPRESSION
ANALYSIS OF AUTOPHAGIC FLUX
The autophagic flux was measured as described previously. (27) Briefly, the cells were pretreated with chloroquine, an inhibitor of lysosome acidification, after SIRT3 overexpression or knockdown. The autophagic flux was determined by detecting GFP-LC3 puncta and LC3-II expression using laser scanning confocal microscopy (Nikon A1R, Japan) and western blot analysis, respectively. Additionally, cells were transiently transfected with recombinant adenovirus mRFP-GFP-LC3 (Hanbio Biotechnology Co. Ltd., Shanghai, China). Yellow or red puncta were detected by confocal microscopy from at least 50 cells for each individual experiment after different treatments.
STATISTICAL ANALYSIS
All data are expressed as the mean 6 standard deviation (SD) of at least three independent experiments. Statistical analysis was performed using one-way analysis of variance and analyzed by post hoc test with Fisher's least significant difference. Differences between treatments were considered statistically significant at P < 0.05.
Results
SIRT3 NEGATIVELY REGULATES AUTOPHAGY IN HEPATOCYTES
To directly test the effect of SIRT3 on autophagy in hepatocytes, a stable SIRT3-overexpressing HepG2 cell line was established (Supporting Fig. S1 ). SIRT3 overexpression strongly decreased intracellular autophagosome formation and microtubule-associated protein 1 light chain 3 (LC3)-II conversion, the wellestablished markers of autophagy induction, whereas increased accumulation of p62, a protein specifically degraded by autophagy, was observed (Fig. 1A) . Moreover, SIRT3 overexpression blunted rapamycininduced autophagy activation (Supporting Fig. S2 ) and attenuated autophagic flux, which was evidenced by reduced autophagosome formation and LC3-II conversion in the presence of chloroquine, and decreased numbers of autophagosomes (yellow puncta) and autolysosomes (red puncta) (Fig. 1A) . Conversely, SIRT3 knockdown via small interfering RNA (siRNA) transfection led to increased LC3-II conversion, decreased p62 accumulation ( Fig. 1B; Supporting Fig. S3 ), and increased autophagic flux (Fig. 1B) . Furthermore, SIRT3
2/2 and the liver-specific SIRT3 overexpression mice were collected. As shown in Figure 1C , SIRT3 2/2 mice manifested enhanced hepatic LC3-II conversion and decreased accumulation of p62 in both fasting and fed states (Fig. 1C) , whereas the mice with liverspecific SIRT3 overexpression manifested decreased LC3-II conversion and increased accumulation of p62 in the liver (Fig. 1D ). Taken together, these data suggest that SIRT3 is a negative regulator of autophagy.
FREE FATTY ACIDS DIFFERENTIALLY REGULATE SIRT3 EXPRESSION IN THE LIVER/HEPATOCYTES
SFA-induced hepatocyte cell death contributes to the pathogenies of NAFLD. (9) We showed that both PA and stearic acid (SA) induced significant cell death (Supporting Fig. S4A-F) , whereas oleic acid (OA) showed no effect on cell viability (Supporting Fig.  S4G ,H). In our in vivo investigations, male C57BL/6 mice were exposed to either an SFA-rich (palm oil) high-fat diet (HFD) or an isocaloric unsaturated fatty acid2rich (corn oil) HFD for 8 weeks. We demonstrate here that the SFA-rich HFD induced more prominent hepatic pathological alterations than the isocaloric unsaturated fatty acid2rich HFD ( Fig. 2A ; Supporting Fig. S5 ). Intriguingly, hepatic SIRT3 expression was significantly elevated in the setting of SFA-rich HFD feeding ( Fig. 2B; Supporting Fig.  S6A ). Correspondingly, mitochondrial protein acetylation status in the liver was significantly reduced in mice fed the SFA-rich HFD (Fig. 2C ).
FIG. 2.
SFAs up-regulate SIRT3 expression and activity in the liver and HepG2 cells. Male C57BL/6 mice were fed a normal diet or HFD using either palm oil or corn oil as a fat source. Plasma and liver were collected for analysis. HepG2 cells were treated with 0.5 mM PA or OA for 12 hours (or treated with the indicated dose and duration in the figure). Total cellular lysates from hepatocytes and liver tissues (n 5 8) were subjected to immunoblotting assay for SIRT3. Mitochondrial proteins were extracted from both hepatocytes and liver tissues using a commercial Mitochondria Isolation kit (Beyotime, China) for the measurement of acetylated protein abundance. To directly determine the effect of different types of fatty acids on SIRT3 expression and activity, cultured hepatocytes were exposed to either PA or OA. PA exposure increased SIRT3 expression in a dose-and time-dependent manner in both human (HepG2) and mouse (AML-12, a nontransformed mouse hepatocyte cell line) hepatocytes ( Fig. 2D; Supporting Fig. S7A,B) without affecting its stability (Supporting Fig. S6B,C) . Accordingly, acetylated mitochondrial protein abundance was reduced by PA exposure ( Fig. 2E ; Supporting Fig. S7C ). OA exposure had no effect on SIRT3 expression (Fig. 2F ).
SIRT3 CONTROLS SENSITIVITY OF HEPATOCYTE/LIVER TO SFA-INDUCED LIPOTOXICITY
SIRT3 up-regulation by PA, but not OA, spurred us to investigate the role of SIRT3 activity in SFAinduced lipotoxicity. Somewhat unexpectedly, SIRT3 overexpression increased cellular susceptibility to PAinduced cell death (Fig. 3A) . In contrast, SIRT3 inhibition, with either a genetic (siRNA transfection) or pharmacologic (nicotinamide) approach, alleviated PA-induced cell death in both control and SIRT3-overexpressing cells ( Fig. 3B-D ; Supporting Figs. S8 and S9). Similar results were observed when SA was applied (Supporting Fig. S10 ). These results suggest that SIRT3 activity modulates the sensitivity of hepatocytes to SFA-induced lipotoxicity. This notion was corroborated by our in vivo investigation using the liver-specific SIRT3 overexpression mice. As shown in Fig. 3E and Supporting Figure S11 , liver-specific SIRT3 overexpression aggravated liver damage in response to an 8-week palm oil2rich HFD feeding.
SIRT3 SENSITIZES HEPATOCYTES TO LIPOTOXICITY VIA NEGATIVELY MEDIATING AUTOPHAGY
In keeping with previous studies, including ours, (9) we showed here that autophagy induction, via several well-established approaches, including rapamycin supplementation, amino acid2 and serum-depleted medium (Earle's balanced salt solution [EBSS]), as well as serum-free medium, provided strong protection against PA-induced cell death (Supporting Fig. S12A,  B) . Conversely, the autophagy inhibitors, bafilomycin A1 and chloroquine, aggravated PA hepatotoxicity (Supporting Fig. S12C,D) . Similar results were observed when SA was used (Supporting Fig. S12E,F) . However, OA supplementation with or without autophagy inhibitors had no effect on cell death (Supporting Fig. S12G,H) .
To determine whether the negative regulation of SIRT3 on autophagy is involved in PA-induced lipotoxicity, rapamycin was exploited to activate autophagy in SIRT3-overexpressing cells before PA exposure. As shown in Figure 4A , rapamycin pretreatment blocked PA-induced lipotoxicity in SIRT3-overexpressing cells. Conversely, autophagy suppression via either pharmacological (chloroquine) or genetic (siRNA for Atg5, Supporting Fig. S13 ) approach blunted the protective effect of SIRT3 siRNA transfection on PAinduced cell death ( Fig. 4B,C; Supporting Fig. S14 ). These results suggest that SIRT3 controls the sensitivity of hepatocytes to PA-induced lipotoxicity via negatively regulating autophagy.
SIRT3 NEGATIVELY REGULATES AUTOPHAGY VIA SUPPRESSING AMPK
AMPK activation induces autophagy by suppressing mammalian target of rapamycin C1 (mTORC1). (28) To determine the role of AMPK in SIRT3-regulated autophagy suppression, we first examined the effect of SIRT3 on AMPK activation. As shown in Figure 5A , SIRT3 overexpression was associated with suppressed AMPK activation, evidenced by decreased protein phosphorylation of AMPK and ACC, an AMPK target protein, as well as increased phospho-p70S6k1, a well-known downstream target of mTORC1 activation. Moreover, SIRT3 overexpression blunted 5-aminoimidazole-4-carboxamide1-b-D-ribofuranoside (AICAR)-instigated AMPK activation (Supporting Fig. S15 ). Conversely, SIRT3 siRNA silencing led to a robust enhancement of AMPK activation and p70S6k1 inhibition ( Fig. 5A; Supporting Fig. S16) . Accordingly, the livers from SIRT3 2/2 mice demonstrated up-regulated p-AMPK and p-ACC levels, as well as decreased phospho-p70S6k1 abundance in comparison with wild-type mice ( Fig. 5B; Supporting  Fig. S17A ), whereas the opposite changes of these proteins were observed in the livers of hepatocyte-specific SIRT3 overexpressing mice (Fig. 5C ).
Inasmuch as the existence of a reverse association between SIRT3 and AMPK activity, we next sought to determine if AMPK is mechanistically implicated in the effect of SIRT3 on autophagy. AMPK siRNA silencing prevented LC3-II conversion and LC3 puncta accumulation resulting from SIRT3 suppression (Fig. 5D ), indicating that AMPK is the main downstream target of SIRT3 in regulating autophagy. Although both ERK1/2 and Akt were reported to regulate autophagy and be potentially impacted by SIRT3 activation, (29) FIG. 4. Autophagy alteration contributes to SIRT3-regulated lipotoxicity in HepG2 cells. (A) SIRT3 OE and vector control HepG2 cells were treated with 0.5 mM PA for 12 hours with or without 1 hour of preincubation with 50 nM rapamycin. Cell death was detected by the measurements of lactate dehydrogenase release and propidium iodide staining, respectively. (B) HepG2 cells were transfected with either scramble siRNA or SIRT3 siRNA overnight, followed by 0.5-mM PA exposure for 12 hours. Autophagy inhibitor chloroquine (20 lM) was added 1 hour ahead of PA treatment. Cell death was detected. (C) HepG2 cells were cotransfected with siRNA for SIRT3 and Atg5 siRNA, followed by 0.5-mM PA exposure for 12 hours. Cell death was detected. All values are expressed as the mean 6 SD from three or more independent batches of cells. Bars with different characters differ significantly (P < 0.05).
their involvement was not supported by our investigations (Supporting Fig. S17) .
PA inhibits AMPK activation in hepatocytes. (30) In accordance, we observed that PA strongly inhibited AMPK activation both in vitro and in vivo, whereas OA activated AMPK (Supporting Fig. S18 ).
Importantly, we showed that silencing AMPK blunted the protection against PA-induced cell death in SIRT3 siRNA-transfected HepG2 cells ( Fig. 5E;  Supporting Fig. S19 ). In contrast, either EBSS (amino acid2 and serum-depleted) or GP starvation (glucose, L-glutamine, pyruvate, and serum-depleted) medium protected against PA-induced cell death in both control and SIRT3-overexpressing cells, both being associated with the strong activation of AMPK and autophagy ( Fig. 5F; Supporting Figs. S20 and S21 ). Taken together, these results suggest that AMPK activation contributes to SIRT3-regulated autophagy and sensitivity to PA-induced lipotoxicity.
ALTERED INTRACELLULAR REDOX STATUS CONTRIBUTES TO THE REGULATORY ROLE OF SIRT3 ON AMPK
Other than altered adenosine monophosphate (AMP)/adenosine triphosphate (ATP) ratio, intracellular redox status modulates AMPK activation. (31) To gain insight into the mechanisms involved in SIRT3-regulated AMPK activation, we first examined the effect of SIRT3 on intracellular redox status. As shown in Figure 6A , SIRT3 overexpression markedly decreased intracellular superoxide (O 2 Á2 ) levels, whereas intracellular hydrogen peroxide (H 2 O 2 ) content was significantly increased. In contrast, siRNA silencing of SIRT3 significantly enhanced intracellular O 2 Á2 levels but reduced H 2 O 2 content ( Fig. 6B ; Supporting Fig. S22 ). These observations directed us to subsequently analyze the effect of O 2 Á2 on AMPK activity and autophagy by treating HepG2 with rotenone, a well-established O 2 Á2 inducer that acts via inhibition of mitochondrial complex I. As expected, rotenone exposure led to a significant increase of intracellular O 2 Á2 production (Supporting Fig. S23A ). Interestingly, cellular p-AMPK level was also markedly increased in response to rotenone exposure (Supporting Fig. S23B ). Importantly, both rotenone-induced O 2 Á2 overproduction and AMPK activation were associated with autophagy induction, as shown by increased LC3-II conversion and LC3 puncta accumulation (Supporting Fig. S23B,C) . Reducing intracellular O 2 Á2 by N-acetylcysteine (NAC), a O 2
Á2
cleaner (Supporting Fig. S24A ), markedly reduced p-AMPK abundance, and inhibited autophagy (Supporting Fig. S24B,C) . Furthermore, we showed that AMPK siRNA silencing abolished rotenone-triggered LC3-II conversion, whereas AICAR-induced LC3-II conversion was not affected by NAC supplementation (Fig. 6C) . Taken together, these data suggest that decreased O 2 Á2 generation contributes to SIRT3 overexpression-induced AMPK inhibition and resultant autophagy suppression in hepatocytes.
Our data support that SIRT3 overexpression-induced autophagy suppression involves AMPK inhibition via depleting cellular O 2 Á2 levels. We next asked whether the alteration of intracellular redox status is able to affect PAinduced lipotoxicity. As shown in Supporting Fig. S25A , increasing intracellular O 2 Á2 by rotenone markedly alleviated PA-induced cell death, which was abolished by both siRNA silencing of AMPK and autophagy inhibition ( Fig. 6D; Supporting Fig. S25B ). In addition, rotenone also alleviated PA-induced cell death in SIRT3-overexpressing cells (Fig. 6E) . Conversely, depleting cellular O 2 Á2 content by NAC aggravated PA-induced lipotoxicity (Supporting Fig. S26 ). Accordingly, NAC blunted the protection conferred by SIRT3 siRNA silencing against PA-induced cell death (Fig. 6F ).
SIRT3 MEDIATED INTRACELLULAR O 2
Á2
HOMEOSTASIS VIA REGULATING MnSOD ACTIVITY SIRT3-mediated deacetylation reaction enhances MnSOD activity, (20) a mitochondrial antioxidant enzyme catalyzing the conversion of O 2 Á2 to H 2 O 2 . In line with previous reports, our result showed that whereas SIRT3 overexpression robustly decreased acetylated MnSOD protein abundance, SIRT3 silencing by siRNA led to increased MnSOD protein acetylation (Fig. 7A,B) . Of note, treatment of HepG2 cells with 2-methoxyestradiol (2-ME), a commonly used MnSOD inhibitor, mimicked the effect of SIRT3 siRNA knockdown on intracellular reactive oxygen species (ROS) production ( Fig, 7C; Supporting Fig. S27A,B) , whereas MnSOD overexpression in HepG2 cells mimicked the effect of SIRT3 overexpression (Fig. 7D) . Correspondingly, 2-ME prevented PA-induced cell death in both normal and SIRT3-overexpressing cells ( Fig. 7E ; Supporting Fig. S27C) , which, as expected, was blunted by autophagy suppression (Supporting Fig. S27D ), whereas MnSOD overexpression suppressed autophagy and aggravated PA-induced cell death ( Fig. 7F; homeostasis were determined. In harmony with its positive effect on SIRT3, a 12-hour PA exposure (0.5 mM) evidently decreased MnSOD protein acetylation (Fig. 8A) . In accordance, PA exposure reduced intracellular O 2 Á2 levels and attenuated rotenone-triggered intracellular O 2 Á2 increase (Fig. 8B,C) .
Discussion
Lipotoxicity plays a pathological role in the development of NAFLD. (32) However, the exact mechanisms underlying SFA-triggered hepatocyte cell death have yet to be fully elucidated. In the present study, we provide evidence for a SIRT3-dependent mechanism exacerbating SFA-induced lipotoxicity in hepatocytes. We demonstrate that hepatic SIRT3 overexpression renders hepatocytes more susceptible to SFA-induced cell death and aggravates NAFLD progression in mice in the setting of SFA-rich HFD feeding by negatively regulating autophagy induction. Our results reveal that AMPK inhibition, resulting from MnSOD activation2derived O 2 Á2 depletion, is mechanistically involved in SIRT3-induced autophagy suppression and aggravated lipotoxicity in hepatocytes (see proposed model in Fig. 8D ).
SIRT3 plays a pivotal role in maintaining mitochondrial protein acylation homeostasis, and thereby metabolism, by deacetylaing critical enzymes in a variety of metabolic pathways. (16) (17) (18) (19) (20) (21) 25) SIRT3 activation is one of the major mechanisms accounting for many calorie restriction-derived benefits. (20, 33) Similarly, the beneficial effects of SIRT3 activation have been reported by numerous studies in a variety of experimental and clinical settings. (34, 35) In this study, we demonstrate that SFAs and unsaturated FAs differentially regulate SIRT3 expression in hepatocytes. Unexpectedly, our data suggest that SIRT3 activation is associated with increased susceptibility of hepatocytes to PA-induced cell death. These observations are in direct contrast with a previous report that HFD feeding down-regulated hepatic SIRT3 expression and that SIRT3 activation conferred beneficial effect on PA-induced hepatotoxicity by preventing oxidative stress derived from mitochondrial dysfunction. (36) These discrepancies are difficult to clarify fully at present. However, one possible explanation is the difference in the SIRT3 overexpression protocol employed. In comparison with the transient SIRT3 overexpression used by Bao et al., (36) our stable overexpression system mimics in vivo experimental conditions and is therefore more clinically relevant. Also noteworthy is that, although oxidative stress has been mechanistically implicated in PA-induced lipotoxicity in several cell types, including hepatocytes, our previous study documented that PA exposure was associated with increased intracellular glutathione concentration in HepG2 cells, (37) suggestive of the existence of oxidative stress-independent mechanisms in PA-induced hepatotoxicity. Furthermore, exacerbated PA-induced hepatocyte cell death by the antioxidant NAC implied that a certain amount of ROS could in fact be required to protect against lipotoxicity. (37) Our studies point to a critical role of SIRT3 as a negative regulator of autophagy in hepatocytes, leading to exacerbated SFA-induced lipotoxicity. Our data reveal that SIRT3 gene silencing/knockout is associated with AMPK activation in hepatocytes and the liver. These observations are consistent with a previous report that demonstrated that the reduced SIRT3 expression represents a fundamental mechanism in metformin-induced AMPK activation in hepatocytes. (38) Conversely, SIRT3 overexpression in HepG2 cells led to a significant inhibition of AMPK activation. This observation disagrees with a previous report showing that SIRT3 overexpression in HepG2 cells was associated with AMPK activation. (39) The transient SIRT3 overexpression system employed in that study might potentially account for the discrepancy. AMPK activation induces autophagy by inhibiting mTORC1, a strong inhibitor of autophagy. (28) Given the well-documented positive role of AMPK activity in the regulation of autophagy, we therefore postulate that AMPK may represent a mechanistic link between SIRT3 and autophagy. This notion is supported by our data that genetic inhibition of AMPK alleviated autophagy induction in SIRT3 siRNA-transfected hepatocytes and abolished SIRT3 silencing-conferred protection against lipotoxicity, while activating AMPK significantly reduced PA-induced cell death in SIRT3-overexpressed hepatocytes. Nevertheless, under a regular diet, mice with liver AAV-SIRT3 OE failed to recapitulate the effects of SIRT3 on AMPK and mTORC1 as observed in SIRT3 OE hepatocytes, despite apparent autophagy induction. This observation implied the existence of the AMPK/mTORC1 signaling pathway-independent mechanism in the regulation of SIRT3 OE-instigated autophagy suppression in the in vivo system. On the other hand, we observed that, under high palm oil-HFD feeding, AAV-SIRT3 OE mice manifested suppressed hepatic AMPK activation and increased mTORC1 activation (p-S6K1) compared with that in AAV-null mice (Fig. 5C) , suggesting that the effect of SIRT3 on the AMPK/mTOR signaling pathway is contextdependent, which may require environmental and/or dietary cues. AMPK is a positive regulator of autophagy. It was previously reported that SIRT3 2/2 mice manifested a significantly reduced hepatic ATP level compared with wild-type animals. (16) Moreover, AMPK activation by metformin was associated with SIRT3 downregulation and the subsequent reduction of cellular ATP levels in both hepatocytes and the liver, which was recovered by SIRT3 overexpression. (39) These observations provided the first line of evidence supporting the existence of a negative relationship between SIRT3 and AMPK. Other than altered AMP/ATP ratio, it was also reported that O 2 Á2 plays an important role in the activation of AMPK and autophagy. (31, 40) To gain further insight into the mechanisms involved in SIRT3-triggered AMPK suppression, we investigated the effect of SIRT3 on ROS production and their role in AMPK activation. Our studies provide initial evidence suggesting that O 2 Á2 depletion plays a mechanistic role in SIRT3 overexpression-induced AMPK suppression. This notion is supported by several findings. First, SIRT3-overexpressing HepG2 cells have significantly low levels of O 2
Á2
, whereas hydrogen peroxide was significantly increased. Conversely, SIRT3 gene silencing was associated with markedly increased O 2 Á2 levels, whereas hydrogen peroxide levels were significantly reduced. Second, rotenone, a potent O 2 Á2 inducer via suppressing mitochondrial complex I, increased cellular O 2 Á2 production, activated AMPK, induced autophagy, and protected HepG2 cells against lipotoxicity. Third, NAC, a potent ROS scavenger, inhibited AMPK and autophagy activation and potentiated PA-induced hepatotoxicity. Finally, MnSOD negatively regulates O 2 Á2 production and AMPK activation. Overall, our studies support the notion that SIRT3-mediated O 2
depletion mechanistically links SIRT3 activation with AMPK suppression.
MnSOD, the mitochondrial form of SOD converting O 2 Á2 into H 2 O 2 , is crucial for the maintenance of mitochondria-generated O 2 Á2 homeostasis. Interestingly, MnSOD is a target of SIRT3, whose deacetylation by SIRT3 results in enhanced enzymatic activity. (20) In line with previous reports, we found that SIRT3 overexpression robustly decreased MnSOD protein acetylation, whereas its silencing by siRNA led to increased acetylated MnSOD. Moreover, we found that MnSOD inhibition mimics SIRT3 gene silencing in terms of the ROS generation pattern, whereas MnSOD overexpression mimics the SIRT3 overexpression phenotype. Importantly, similar to SIRT3 siRNA transfection, MnSOD inhibition prevented PA-induced cell death in both normal and SIRT3-overexpressing HepG2 cells. These data suggest that SIRT3 mediates mitochondria-derived O 2 Á2 protection by affecting MnSOD acetylation status.
The negative effect of palmitate on AMPK has been reported previously in several cell types, including hepatocytes, though the exact mechanisms remain unclear. The ceramide-dependent PP2A activation seemed to play an important role in palmitate-induced AMPK dephosphorylation/suppression. (41, 42) Moreover, palmitate-induced PPAR-a suppression was also reported to contribute to AMPK inhibition. (43) The cell culture experiments in the present study provided strong evidence that SIRT3 up-regulation is mechanistically involved in palmitate-elicited AMPK suppression. At the same time, we also recognized that our in vitro observations were not able to be completely recapitulated in our in vivo investigations. Specifically, our data showed that long-term high palm oil-HFD feeding exerted a more profound effect on the AMPK/ mTORC1 signaling pathway than did AAV-SIRT3 overexpression. Therefore, the role of SIRT3-independent pathways in the regulation of palmitateinduced AMPK inhibition cannot be excluded and require further investigation.
In conclusion, this study provides initial experimental evidence that SFA exposure of hepatocytes leads to SIRT3 up-regulation and activation both in vitro and in vivo, which in turn exacerbates SFA-triggered hepatotoxicity by negatively regulating autophagy induction. Intriguingly, our studies reveal that AMPK activation due to MnSOD activation2dependent O 2 Á2 depletion plays a mechanistic role in SIRT3-mediated autophagy suppression in hepatocytes. Given that the both muscle-and liver-specific SIRT3 knockout mice do not manifest any overt metabolic phenotype under either chow or HFD conditions (44) and that SIRT3 knockout mice are protected from acetaminophen-induced hepatotoxicity, (45) our findings suggest that curbing SIRT3 overactivation can be a potential therapeutic choice for the treatment of NAFLD as well as other metabolic disorders, with lipotoxicity being the principal pathomechanism.
